Literature DB >> 1590793

Platelet-derived endothelial cell growth factor has thymidine phosphorylase activity.

K Usuki1, J Saras, J Waltenberger, K Miyazono, G Pierce, A Thomason, C H Heldin.   

Abstract

Platelet-derived endothelial cell growth factor (PD-ECGF), a protein which stimulates angiogenesis in vivo, is shown to have a 39.2% amino acid sequence similarity over a 439 amino acid region with the thymidine phosphorylase of Escherichia coli (E. coli). Using recombinant human PD-ECGF, we show that PD-ECGF has thymidine phosphorylase activity. Analysis by gel chromatography revealed that recombinant human PD-ECGF occurs as a 90 kDa homodimer, similar to other thymidine phosphorylases. In addition to a possible effect on DNA synthesis, PD-ECGF was shown to affect [3H]thymidine assays in a manner which is not related to cell proliferation. The in vitro and in vivo effects of PD-ECGF may thus occur by an indirect mechanism through its enzymatic activity.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1590793     DOI: 10.1016/s0006-291x(05)80025-7

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  41 in total

1.  Thymidine phosphorylase influences [(18)F]fluorothymidine uptake in cancer cells and patients with non-small cell lung cancer.

Authors:  Seung Jin Lee; Jeong Seok Yeo; Haeng Jung Lee; Eun Jung Lee; Seog Young Kim; Se Jin Jang; Jong Jin Lee; Jin-Sook Ryu; Dae Hyuk Moon
Journal:  Eur J Nucl Med Mol Imaging       Date:  2014-02-22       Impact factor: 9.236

Review 2.  Angiogenic growth factors in myocardial infarction: a critical appraisal.

Authors:  Hemalatha Thiagarajan; UmaMaheswari Thiyagamoorthy; Iswariya Shanmugham; Gunadharini Dharmalingam Nandagopal; Anbukkarasi Kaliyaperumal
Journal:  Heart Fail Rev       Date:  2017-11       Impact factor: 4.214

3.  Structural basis for non-competitive product inhibition in human thymidine phosphorylase: implications for drug design.

Authors:  Kamel El Omari; Annelies Bronckaers; Sandra Liekens; Maria-Jésus Pérez-Pérez; Jan Balzarini; David K Stammers
Journal:  Biochem J       Date:  2006-10-15       Impact factor: 3.857

Review 4.  Thymidine Phosphorylase in Cancer; Enemy or Friend?

Authors:  Yasir Y Elamin; Shereen Rafee; Nemer Osman; Kenneth J O Byrne; Kathy Gately
Journal:  Cancer Microenviron       Date:  2015-08-23

5.  Thymidilate synthase expression predicts longer survival in patients with stage II colon cancer treated with 5-flurouracil independently of microsatellite instability.

Authors:  Marisa Donada; Serena Bonin; Ermanno Nardon; Alessandro De Pellegrin; Giuliana Decorti; Giorgio Stanta
Journal:  J Cancer Res Clin Oncol       Date:  2010-04-13       Impact factor: 4.553

Review 6.  The biology of radioresistance: similarities, differences and interactions with drug resistance.

Authors:  S N Powell; E H Abraham
Journal:  Cytotechnology       Date:  1993       Impact factor: 2.058

7.  Effects of platelet-derived endothelial cell growth factor/thymidine phosphorylase, substrate, and products in a three-dimensional model of angiogenesis.

Authors:  D P Stevenson; S R Milligan; W P Collins
Journal:  Am J Pathol       Date:  1998-06       Impact factor: 4.307

Review 8.  TAS-102: a novel antimetabolite for the 21st century.

Authors:  Nataliya Uboha; Howard S Hochster
Journal:  Future Oncol       Date:  2015-11-30       Impact factor: 3.404

9.  In vivo effects of vascular endothelial growth factor on the chicken chorioallantoic membrane.

Authors:  J Wilting; B Christ; M Bokeloh; H A Weich
Journal:  Cell Tissue Res       Date:  1993-10       Impact factor: 5.249

10.  Targeted deletion of both thymidine phosphorylase and uridine phosphorylase and consequent disorders in mice.

Authors:  Misako Haraguchi; Hiroaki Tsujimoto; Masakazu Fukushima; Itsuro Higuchi; Hideto Kuribayashi; Hideo Utsumi; Atsuo Nakayama; Yoshio Hashizume; Junko Hirato; Hiroki Yoshida; Hiromitsu Hara; Shinjiro Hamano; Hiroaki Kawaguchi; Tatsuhiko Furukawa; Kohei Miyazono; Fuyuki Ishikawa; Hideo Toyoshima; Tadashi Kaname; Masaharu Komatsu; Zhe-Sheng Chen; Takenari Gotanda; Tokushi Tachiwada; Tomoyuki Sumizawa; Kazutaka Miyadera; Mitsuhiro Osame; Hiroki Yoshida; Tetsuo Noda; Yuji Yamada; Shin-ichi Akiyama
Journal:  Mol Cell Biol       Date:  2002-07       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.